Research Article
[Retracted] Endostatin Inhibits Blood-Retinal Barrier Breakdown in Diabetic Rats by Increasing the Expression of ICAM-1 and VCAM-1 and Decreasing the Expression of VEGF
Figure 1
Histopathology of diabetic retinopathy. Histological evaluation of retina tissues from STZ-injected rats revealed an increased signs of diabetic retinopathy with edema and inflammatory cell infiltration. Treatment with endostatin reduced the degree of diabetic retinopathy.